Detection of beta-lactamase production in clinical Prevotella species by MALDI-TOF MS method.
Anaerobic bacteria
MALDI-TOF mass Spectrometry
Prevotella
VITEK MS
cfxA gene
β-lactamase
Journal
Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
14
05
2020
revised:
08
07
2020
accepted:
09
07
2020
pubmed:
10
8
2020
medline:
23
6
2021
entrez:
10
8
2020
Statut:
ppublish
Résumé
Penicillins, can be used in treatment of infections due to Prevotella species if they are susceptible to penicillin. Early and accurate preliminary detection of β-lactamase-producing isolates is crucial for treatment of infection. The aim of this study was to determine β-lactamase-producing Prevotella species by MALDI-TOF MS and screen them for the presence of cfxA gene, responsible for β-lactamase production. A total of 500 clinically relevant Prevotella isolates, collected from 13 countries for the previous European antibiotic resistance surveillance study, were tested. Susceptibility testing was performed against ampicillin and ampicillin/sulbactam by Etest methodology. EUCAST guidelines were used for susceptibility interpretations; the isolates with MIC value ≤ 0.5 for ampicillin were considered susceptible and >2 resistant. All Prevotella isolates, were tested for detection of β-lactamase activity by MALDI-TOF MS (Vitek® MS Research Use Only) system and the presence of the cfxA gene by PCR method. The susceptibility levels of the isolates to ampicillin/sulbactam and ampicillin were 99.6% and 43.4%, respectively. A total 59% of isolates presented β-lactamase activity and 60.8% were cfxA gene positive. Both these tests were positive for isolates in the resistant category. Additionally, >95% of the isolates (n = 65) which ampicillin MIC values ranged from >0.5 μg/mL to 2 μg/ml displayed β-lactamase activity. We also found that the MALDI-TOF MS-based β-lactamase assay delivers results in 2 h. We found a high concordance between the MALDI-TOF MS β-lactamase results in terms of cfxA β-lactamase gene presence. MALDI-TOF MS may serve as a simple and efficient alternative method of the existing phenotypic and PCR-based methods.
Identifiants
pubmed: 32768494
pii: S1075-9964(20)30096-2
doi: 10.1016/j.anaerobe.2020.102240
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
102240Investigateurs
Eva Leitner
(E)
Ingrid Wybo
(I)
Vesna Tripkovic
(V)
Ulrik S Justesen
(US)
Helene Jean-Pierre
(H)
Suzana C Stingu
(SC)
Arne C Rodloff
(AC)
Joseph Paparaskevas
(J)
Edit Urban
(E)
Wafaa Jamal
(W)
Vincent O Rotimi
(VO)
Alida C M Veloo
(ACM)
Samo Jeverica
(S)
Guven Kulekci
(G)
Hrisi B Tokman
(HB)
Trefor Morris
(T)
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors; Professor E. Nagy, J.Soki and N. Ulger Toprak were members of ESGAI, Professor G. Soyletir and O. Akgul have no conflicts of interest to declare.